RECOMBINANT FACTOR-VIII (RECOMBINATE) - KEY ISSUES IN SAFETY AND EFFICACY

被引：0
|
作者：
GOMPERTS, ED [1 ]
机构：
[1] BAXTER HEALTHCARE CORP,HYLAND DIV,GLENDALE,CA
来源：
TRANSFUSION | 1992年 / 32卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：485 / 485
页数：1
相关论文
共 50 条
  • [1] A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE) - SAFETY, EFFICACY, AND INHIBITOR RISK IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A
    BRAY, GL
    GOMPERTS, ED
    COURTER, S
    GRUPPO, R
    GORDON, EM
    MANCOJOHNSON, M
    SHAPIRO, A
    SCHEIBEL, E
    WHITE, G
    LEE, M
    GORDON, M
    BERTALONE, S
    LIPTON, R
    HILGARTNER, M
    ARKIN, S
    GILL, J
    KIM, H
    SHURIN, S
    SANTIAGOBORRERO, P
    ARKEL, YS
    KULKARNI, R
    GREENWOOD, MF
    RITCHEY, AK
    WERNER, E
    HAIRE, WD
    KISKER, T
    NEUFELD, E
    EWENSTEIN, B
    DEBIASI, R
    LAURIAN, Y
    KREUZ, W
    RODEGHIERO, F
    INGERSLEV, J
    GAZENGEL, C
    DIMICHELE, D
    COOPER, H
    BLOOD, 1994, 83 (09) : 2428 - 2435
  • [2] SUMMARY OF CLINICAL-EXPERIENCE WITH RECOMBINANT FACTOR-VIII PRODUCTS - RECOMBINATE
    WHITE, GC
    ANNALS OF HEMATOLOGY, 1994, 68 : S7 - S8
  • [3] THROMBIN ACTIVATION OF RECOMBINANT FACTOR-VIII (RECOMBINATE) - CHARACTERIZATION OF RESULTANT POLYPEPTIDES
    ANDRADE, J
    APFELZWEIG, R
    AMPHLETT, G
    KORTE, J
    LIU, SL
    BESMAN, MJ
    TRANSFUSION, 1992, 32 (05) : 484 - 484
  • [4] POTENCY ISSUES WITH RECOMBINANT FACTOR-VIII
    BARROWCLIFFE, T
    ANNALS OF HEMATOLOGY, 1994, 68 : S89 - S91
  • [5] ANAPHYLAXIS FOLLOWING THE USE OF RECOMBINANT FACTOR-VIII (RECOMBINATE, BAXTER-HYLAND)
    SHOPNICK, RI
    BRETTLER, DB
    KAZEMI, M
    GOMPERTS, ED
    BLOOD, 1994, 84 (10) : A467 - A467
  • [6] THE PHARMACOKINETICS OF RECOMBINANT FACTOR-VIII (RECOMBINATE(R)) UNDER CONTINUOUS-INFUSION
    LEE, M
    KESSLER, C
    WHITE, GC
    GOMPERTS, ED
    COURTER, SG
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1015 - 1015
  • [7] IMMUNOLOGICAL SAFETY OF RECOMBINANT FACTOR-VIII
    ABILDGAARD, CF
    SEMINARS IN HEMATOLOGY, 1991, 28 (02) : 44 - 44
  • [8] CLINICAL SAFETY OF RECOMBINANT FACTOR-VIII
    BRACKMAN, HH
    EGLI, JE
    VANLOO, B
    SEMINARS IN HEMATOLOGY, 1991, 28 (02) : 37 - 42
  • [9] CLINICAL EFFICACY OF RECOMBINANT FACTOR-VIII
    ARKIN, S
    ROSE, E
    FORSTER, A
    ALEDORT, LM
    SEMINARS IN HEMATOLOGY, 1991, 28 (02) : 47 - 51
  • [10] SAFETY, EFFICACY AND INHIBITOR RISK OF RECOMBINANT FACTOR-VIII (RECOMBINATE(R)) IN A COHORT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH SEVERE HEMOPHILIA-A
    BRAY, GL
    COURTER, S
    LYNES, M
    LEE, M
    GOMPERTS, E
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1205 - 1205
12345